Seaport will use the funds for its neuropsychiatric drug pipeline, while Hemab will focus on bleeding disorder medicines.

The rapidly approaching SpaceX IPO will be groundbreaking, forcing index providers and underwriters to adapt to a new era of ...

April 27 (Reuters) - Drug developers Seaport Therapeutics and Hemab Therapeutics launched their U.S. initial public offerings ...

The mining company said it has identified what it believes is the optimal structure for a separate listing of the assets, ...

Elon Musk's SpaceX set to produce 'own GPUs' at its own multi-billion fab as the company warns that it may be unable to ...

The IPO market is stalling as volatility and fears about artificial intelligence reshape the overall listings landscape.

Goldman Sachs expects about 100 IPOs raising $160B in 2026, down from a prior forecast of 120 deals for the same total value, ...

CATL has completed a roughly $5 billion share sale in Hong Kong on Tuesday. Meanwhile, Chinese inverter and battery manufacturing giant Sungrow is making a second attempt at an IPO after its initial ...

Anthropic's pre-IPO valuation crossed $1T on Jupiter's Prestocks, up 733% since October, with Forge Global confirming the ...

Compare the best pre-IPO tokens in 2026 by company demand, token structure, liquidity, valuation risk, and holder rights.